EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Stratified Use of Genetic Testing in Liver Disease Improves Diagnostic Yield and Clinical Impact

Angelo Corso Faini iD, Michele Pinon, Giulia Margherita Brach Del Prever iD, Carmelo Maria Romeo, Maria Luca iD, Fiorenza Mioli, Claudia Saglia iD, Caterina Scolari, Tullia Carradori, Francesca Arruga, Cristina Chiadò, Anna Morgando und 7 weitere

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27177906 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Angelo Corso Faini und 18 weiteren Autor:innen. Beteiligte Einrichtung: Immunogenetics and Transplant Biology Service, AOU Città della Salute e della Scienza Hospital, 10126 Turin, Italy. Hauptthemen laut MEDLINE: Genetic Testing, Liver Diseases. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Istruzione e del Merito, University of Turin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genetic testing plays an important role in the diagnosing of liver diseases, but its diagnostic performance varies across patient populations. By analyzing diagnostic yield across patient subgroups, this study aims at defining age-tailored diagnostic workflows for a more effective integration of genetic testing into clinical practice. We retrospectively analyzed 203 patients (145 children, 58 adults) with acute or subacute liver disorders of suspected genetic origin who underwent next-generation sequencing, categorized them by clinical diagnosis, and evaluated diagnostic yields to develop age-tailored testing workflows. The median age was 8 years; 65.5% were male, 84.7% White, and 27.6% had undergone liver transplantation. Cholestatic liver disorders (30%) and unexplained liver dysfunction (20.2%) were the most common indications for testing. Overall, genetic testing achieved a definitive diagnosis in 35.5% of patients, with a higher yield in children than adults (41.4% vs. 20.7%). Metabolic disorders had the highest diagnostic yield (83.3%), while PFIC/BRIC and Alagille syndrome were the most frequent genetic diagnoses. Age-specific diagnostic workflows retrospectively enriched the overall diagnostic rate by approximately 11% across age and disease categories. These findings demonstrate that tailoring genetic testing strategies to patient age and clinical presentation can improve diagnostic efficiency and support a standardized integration of genetic testing into hepatology practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TestingLiver DiseasesHumansMaleFemaleChildRetrospective StudiesChild, PreschoolAdultAdolescentHigh-Throughput Nucleotide SequencingInfantYoung AdultMiddle Aged

Stichwörter der Autor:innen

genetic testinghigh-throughput nucleotide sequencingliver diseases

Autor:innen und Institutionen

  • Immunogenetics and Transplant Biology Service, AOU Città della Salute e della Scienza Hospital, 10126 Turin, Italy.
  • Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
  • Pediatric Gastroenterology Division, Regina Margherita Children's Hospital, 10126 Turin, Italy.
  • Division of Gastroenterology, AOU Città della Salute e della Scienza Hospital, 10126 Turin, Italy.
  • SSD Insufficienza Epatica e Trapianto Epatico, AOU Città della Salute e della Scienza Hospital, 10126 Turin, Italy.
  • General Surgery 2U and Liver Transplantation Center, AOU Città della Salute e della Scienza Hospital, 10126 Turin, Italy.

ORCID-Profile: Angelo Corso Faini, Giulia Margherita Brach Del Prever, Maria Luca, Claudia Saglia, Silvia Martini, Renato Romagnoli, Elisabetta Bugianesi, Diana Carli, Tiziana Vaisitti, Silvia Deaglio, Pier Luigi Calvo

Förderung

  • Ministero dell'Istruzione e del Merito
  • University of Turin

Zitieren

APA

Faini, A. C., Pinon, M., Brach Del Prever, G. M., Romeo, C. M., Luca, M., Mioli, F., Saglia, C., Scolari, C., Carradori, T., Arruga, F., Chiadò, C., Morgando, A., Martini, S., Romagnoli, R., Bugianesi, E., Carli, D., Vaisitti, T., Deaglio, S., & Calvo, P. L. (2026). Stratified Use of Genetic Testing in Liver Disease Improves Diagnostic Yield and Clinical Impact. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27177906

Vancouver

Faini AC, Pinon M, Brach Del Prever GM, Romeo CM, Luca M, Mioli F, et al. Stratified Use of Genetic Testing in Liver Disease Improves Diagnostic Yield and Clinical Impact. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27177906

BibTeX
@article{Faini2026,
  author = {Faini, Angelo Corso and Pinon, Michele and Brach Del Prever, Giulia Margherita and Romeo, Carmelo Maria and Luca, Maria and Mioli, Fiorenza and Saglia, Claudia and Scolari, Caterina and Carradori, Tullia and Arruga, Francesca and Chiadò, Cristina and Morgando, Anna and Martini, Silvia and Romagnoli, Renato and Bugianesi, Elisabetta and Carli, Diana and Vaisitti, Tiziana and Deaglio, Silvia and Calvo, Pier Luigi},
  title = {Stratified Use of Genetic Testing in Liver Disease Improves Diagnostic Yield and Clinical Impact},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27177906}
}
Kostenlos starten →